Medical News Summary: Vioxx approved for treatment of juvenile rheumatoid arthritis
About: Vioxx approved for treatment of juvenile rheumatoid arthritis
Date: 7 December 2004
Source: News Target Network
Medical News Summary (summary of medical news story as reported by News Target Network): The FDA has approved the use of Vioxx for children suffering from common forms of juvenile rheumatoid arthritis (pauciarticular, polyarticular). The children need to be over 2 years old and weigh more than 22 pounds. Vioxx has already been approved for use in treatment of severe migraine in adults. The approval was based on a study involving 310 patients.
URL: http://www.newstarget.com/002718.html
Related Disease Topics: Juvenile rheumatoid arthritis, Arthritis, Rheumatoid arthritis, Pauciarticular juvenile rheumatoid arthritis, Polyarticular juvenile rheumatoid arthritis, Migraine
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Medication
- medication and juvenile rheumatoid arthritis
- medication and arthritis
- medication and rheumatoid arthritis
- Medication and pauciarticular juvenile rheumatoid arthritis
- Medication and polyarticular juvenile rheumatoid arthritis
- medication and migraine
- Research
- research and juvenile rheumatoid arthritis
- research and arthritis
- research and rheumatoid arthritis
- Research and pauciarticular juvenile rheumatoid arthritis
- Research and polyarticular juvenile rheumatoid arthritis
- research and migraine
Medical Tools & Articles:
Next articles:
Medical Articles: